PHP

Parkman Healthcare Partners Portfolio holdings

AUM $911M
1-Year Est. Return 51.9%
This Quarter Est. Return
1 Year Est. Return
+51.9%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$911M
AUM Growth
+$46.3M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
103
New
Increased
Reduced
Closed

Top Buys

1
+$18.2M
2
+$14.8M
3
+$12.9M
4
MCK icon
McKesson
MCK
+$8.56M
5
FOLD icon
Amicus Therapeutics
FOLD
+$8.5M

Top Sells

1
+$19.2M
2
+$18.7M
3
+$17.8M
4
RVTY icon
Revvity
RVTY
+$15.2M
5
IQV icon
IQVIA
IQV
+$15.1M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DVAX icon
76
Dynavax Technologies
DVAX
$1.28B
$2.69M 0.28%
271,306
+1,175
TVRD
77
Tvardi Therapeutics
TVRD
$42.5M
$2.53M 0.26%
+65,000
SLDB icon
78
Solid Biosciences
SLDB
$458M
$2.45M 0.26%
+396,396
DAWN icon
79
Day One Biopharmaceuticals
DAWN
$874M
$2.13M 0.22%
301,746
-198,254
RARE icon
80
Ultragenyx Pharmaceutical
RARE
$3.49B
$2.06M 0.22%
68,636
-79,344
FDMT icon
81
4D Molecular Therapeutics
FDMT
$619M
$1.74M 0.18%
+200,000
QTRX icon
82
Quanterix
QTRX
$356M
$1.37M 0.14%
252,211
-263,781
ANNX icon
83
Annexon
ANNX
$730M
$1.24M 0.13%
405,953
+1,759
BFLY icon
84
Butterfly Network
BFLY
$770M
$1.16M 0.12%
+602,192
MASS icon
85
908 Devices
MASS
$238M
$879K 0.09%
100,368
+368
LUNG icon
86
Pulmonx
LUNG
$101M
$811K 0.08%
500,662
-104,367
CMPS
87
Compass Pathways
CMPS
$642M
$573K 0.06%
+100,000
ENTX icon
88
Entera Bio
ENTX
$97.2M
$539K 0.06%
280,822
-75,000
EDAP
89
EDAP TMS
EDAP
$87.9M
$355K 0.04%
154,832
OVID icon
90
Ovid Therapeutics
OVID
$115M
$264K 0.03%
+202,978
MRUS icon
91
Merus
MRUS
$7.34B
– –
-162,980
NRIX icon
92
Nurix Therapeutics
NRIX
$1.99B
– –
-228,271
QQQ icon
93
Invesco QQQ Trust
QQQ
$408B
– –
0
REPL icon
94
Replimune Group
REPL
$770M
– –
-896,710
RVTY icon
95
Revvity
RVTY
$11.7B
– –
-157,196
VRNA
96
DELISTED
Verona Pharma
VRNA
– –
-197,898
ATYR
97
aTyr Pharma
ATYR
$80M
– –
-150,000
PHLT
98
DELISTED
Performant Healthcare Inc
PHLT
– –
-1,214,272
ALKS icon
99
Alkermes
ALKS
$4.73B
– –
0
ANIP icon
100
ANI Pharmaceuticals
ANIP
$1.84B
– –
-128,478
1 2 3
4
5